Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

PerkinElmer to Market Newborn Screening System

Photonics.com
Nov 2002
BOSTON, Nov. 14 -- PerkinElmer Inc., the leading provider of solutions to newborn screening laboratories, said it is the first company to receive FDA 510(k) clearance to market a comprehensive screening system to identify whether a newborn may become developmentally impaired or risk premature death. PerkinElmer's NeoGram Phenylalanine Test System, consisting of a reagent kit, application software and tandem mass spectrometer, will be used to identify a disorder known as phenylketonuria (PKU) in newborns.

The reagent kit is designed to run exclusively on tandem mass spectrometry equipment, a new technology for newborn screening, PerkinElmer said.

For more information, visit: lifesciences.perkinelmer.com



Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.